Vaxart, Inc. - VXRT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | SVP, Chief Scientific Officer | F | D | 3,924.0 | 0.65 | 2,550.6 | 882,811.0 | View | |
| Mar 31, 2026 | Chief Medical Officer | F | D | 3,292.0 | 0.65 | 2,139.8 | 924,177.0 | View | |
| Mar 26, 2026 | President, Chief Exec Officer | F | D | 126,028.0 | 0.694 | 87,463.43 | 2,485,606.0 | View | |
| Mar 26, 2026 | Chief Medical Officer | F | D | 30,551.0 | 0.694 | 21,202.39 | 927,469.0 | View | |
| Mar 26, 2026 | SVP, General Counsel | F | D | 36,418.0 | 0.694 | 25,274.09 | 755,368.0 | View | |
| Mar 26, 2026 | SVP, Chief Scientific Officer | F | D | 36,418.0 | 0.694 | 25,274.09 | 886,735.0 | View | |
| Mar 20, 2026 | President, Chief Exec Officer | F | D | 22,425.0 | 0.6346 | 14,230.91 | 2,611,634.0 | View | |
| Mar 20, 2026 | Chief Medical Officer | F | D | 6,772.0 | 0.6346 | 4,297.51 | 958,020.0 | View | |
| Mar 20, 2026 | SVP, General Counsel | F | D | 8,072.0 | 0.6346 | 5,122.49 | 791,786.0 | View | |
| Mar 20, 2026 | SVP, Chief Scientific Officer | F | D | 8,072.0 | 0.6346 | 5,122.49 | 923,153.0 | View | |
| Mar 18, 2026 | Chief Medical Officer | A | A | 455,000.0 | 0.0 | 0.0 | 455,000.0 | View | |
| Mar 18, 2026 | Chief Medical Officer | A | A | 227,000.0 | 0.0 | 0.0 | 964,792.0 | View | |
| Mar 18, 2026 | Chief Financial Officer | A | A | 455,000.0 | 0.0 | 0.0 | 455,000.0 | View | |
| Mar 18, 2026 | Chief Financial Officer | A | A | 227,000.0 | 0.0 | 0.0 | 577,000.0 | View | |
| Mar 18, 2026 | SVP, Chief Scientific Officer | A | A | 410,000.0 | 0.0 | 0.0 | 410,000.0 | View | |
| Mar 18, 2026 | SVP, Chief Scientific Officer | A | A | 200,000.0 | 0.0 | 0.0 | 931,225.0 | View | |
| Mar 18, 2026 | President, Chief Exec Officer | A | A | 1,543,000.0 | 0.0 | 0.0 | 1,543,000.0 | View | |
| Mar 18, 2026 | President, Chief Exec Officer | A | A | 846,500.0 | 0.0 | 0.0 | 2,634,059.0 | View | |
| Mar 18, 2026 | SVP, General Counsel | A | A | 225,000.0 | 0.0 | 0.0 | 225,000.0 | View | |
| Mar 18, 2026 | SVP, General Counsel | A | A | 115,000.0 | 0.0 | 0.0 | 799,858.0 | View | |
| Feb 05, 2026 | SVP, Chief Scientific Officer | F | D | 9,265.0 | 0.6085 | 5,637.75 | 731,225.0 | View | |
| Feb 05, 2026 | SVP, General Counsel | F | D | 9,265.0 | 0.6085 | 5,637.75 | 684,858.0 | View | |
| Feb 05, 2026 | Chief Medical Officer | F | D | 7,965.0 | 0.6085 | 4,846.7 | 737,792.0 | View | |
| Dec 08, 2025 | President, Chief Exec Officer | F | D | 54,153.0 | 0.37 | 20,036.61 | 1,787,559.0 | View | |
| Dec 08, 2025 | President, Chief Exec Officer | A | A | 151,351.0 | 0.0 | 0.0 | 1,841,712.0 | View | |
| Dec 05, 2025 | — | P | A | 5,000.0 | 0.407 | 2,035.0 | 124,125.0 | View | |
| Dec 05, 2025 | — | P | A | 15,000.0 | 0.41 | 6,150.0 | 119,125.0 | View | |
| Nov 21, 2025 | — | P | A | 16,783.0 | 0.405 | 6,797.12 | 96,566.0 | View | |
| Nov 21, 2025 | — | P | A | 23,217.0 | 0.393 | 9,124.28 | 79,783.0 | View |